Todd Kole Appointed to Almac’s Clinical Technologies Executive Team
News Aug 30, 2011
Almac’s Clinical Technologies business unit has announced that Todd Kole has joined the company as Vice President of Clinical Project Services (CPS) and a member of the Executive Leadership Team.
As Vice President of CPS, Todd will report directly to the President of Almac Clinical Technologies and will oversee clinical project management and drug supply services globally.
Mr. Kole has extensive experience in the biopharmaceuticals industry, with specialized expertise in clinical technologies and clinical supplies management.
He has served in a variety of capacities involving the provision of Interactive Voice and Web Response Systems (IVR/IWR) technologies, clinical and technology personnel management, as well as global project and client account management.
Mr. Kole joins Almac after spending 12 years at Clinphone and Perceptive Informatics. At Clinphone, Mr. Kole served as Director of US Operations before being promoted to Vice President of Global Client Services.
In operations roles at Clinphone he was responsible for approximately 175 staff, ensuring operational accountability in managing the quality and timeliness of IVRS design, build, delivery and support.
As VP of Client Services at Clinphone, he held global oversight responsibilities for the Project Management and Client Account Management divisions.
During his tenure as Vice President of IVR Operations at Perceptive Informatics, Mr. Kole held P&L responsibilities and was a member of the Perceptive Executive Management Team.
In that role, he was integral in working with clients and operations personnel during the acquisition of Clinphone by Perceptive Informatics.
Jim Murphy, President of Almac's Clinical Technologies business unit comments on Mr. Kole’s appointment: “We are very pleased that Todd Kole has joined Almac. He brings a tremendous amount of industry experience to our firm that will help Almac maintain high levels of operational excellence as we continue to grow. Further, given the depth of his drug supply expertise, Todd will be instrumental to the continuing advancement of Almac’s market leading total drug supply chain management service. We welcome Todd to Almac and know he will have a profound impact on the development of the team and our client relationships.”
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria with antibiotics, researchers treated infected mice with molecules that block toxin formation in bacteria.READ MORE
2nd AI Pharma Innovation: Drug Discovery 2019 Summit
Feb 27 - Feb 28, 2019
5th International Congress on Epigenetics & Chromatin
Aug 22 - Aug 23, 2019
14th World Congress on Medicinal Chemistry and Drug Design
Jun 10 - Jun 11, 2019
International Conference on e-Health and Healthcare Innovations
May 08 - May 09, 2019